Certara Corporation Signs Partnership Agreement With ChemAxon Ltd.
Published: Mar 19, 2013
ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, announced that Certara and ChemAxon have signed a partnership agreement. The partnership will focus on providing seamless access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle via Certara’s D360. D360 is an integrated solution for query, analysis and visualization of scientific data. It is used by pharmaceutical and biotech companies to provide unified access to disparate data sources throughout drug discovery and development, greatly improving research productivity. The agreement with ChemAxon provides standard D360 support for ChemAxon’s popular chemical structure sketching tool, MarvinSketch, and JChem Chemistry data cartridge, which are used by many drug discovery scientists across the industry.